Source: MarketScreener

Shanghai Fudan-zhangjiang: Shanghai Fudan Zhangjiang Bio Pharmaceutical : Interim Report For the Six Months Ended 30 June 2020

(marketscreener.com) 上 海 復 旦 張 江 生 物 醫 藥 股 份 有 限 公 司 Shanghai Fudan-ZhangjiangBio-Pharmaceutical Co., Ltd. * INTERIM...https://www.marketscreener.com/quote/stock/SHANGHAI-FUDAN-ZHANGJIANG-6171207/news/Shanghai-Fudan-Zhangjiang-Bio-Pharmaceutical-Interim-Report-For-the-Six-Months-Ended-30-June-2020-31264716/?utm_medium=RSS&utm_content=20200910

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
CEO Avatar

General Manager

Haibo Wang

CEO Approval Rating

70/100

Read more